$LEVI

Singh Harmit J sold $2.4M of LEVI

Singh Harmit J (EVP & Chief Fin. & Growth Ofc.) sold 98,144 shares of LEVI STRAUSS & CO (LEVI) at $24.22 ($2.38M total) on 2026-07-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Singh Harmit J
Published Jul 25, 2026, 1:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 25, 2026, 2:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LEVI
Neutral
high confidence
Mentioned
$LEVI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEVINeutralLow
01

Why it matters

This provides incremental transparency on insider activity but does not introduce new guidance, financial results, or regulatory developments for LEVI.

02

Market read

Traders may monitor insider selling trends, but the planned nature of the sale suggests limited fundamental impact.

03

What to watch

The article does not state total compensation, tax context, or whether sales were part of a broader scheduled cadence, which can reduce interpretability of the signal.

Relevance 5/10Novelty 3/10Timing: Filed 2026-07-24 after the sale on 2026-07-23

Background

The article is an SEC Form 4 insider transaction for LEVI, reporting an open-market sale by an EVP under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$LEVINeutralHigh confidence
Context

LEVI insider Form 4 shows EVP Harmit J. Singh sold 98,144 shares at $24.22 on 2026-07-23 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only and typically muted for planned 10b5-1 sales.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly marked as pre-arranged under Rule 10b5-1, and provides no new company fundamentals beyond the sale details.

Market effects

No sector read-across; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with private views on valuation or liquidity needs, so some traders may still treat it as a mild negative signal.

Key entities

  • LEVI Strauss & Co

    Company whose insider transaction is disclosed on Form 4.

  • Harmit J. Singh

    EVP and Chief Financial and Growth Officer who sold shares.

  • Rule 10b5-1 plan

    Pre-arranged plan indicating the sale was scheduled in advance.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LEVIHighAI 8/10

What Levi Strauss & Co. (LEVI) Said on Its Q3 Earnings Call

Levi Strauss (LEVI) reported Q3 revenue growth of 4% (5% organic), driven by international markets and non-denim categories. Asia and China revenue rose 10% and 13%, respectively. Tariff refunds added $80M in benefits, with most reinvested. The company raised its fiscal 2026 revenue growth forecast to 7% and adjusted EPS to $1.54-$1.56. John Vandemore will become CFO.

$LEVIMedAI 8/10

Levi Strauss Q3 2026 Earnings Call: Complete Transcript - Levi Strauss (NYSE:LEVI)

Levi Strauss (NYSE:LEVI) reported 5% organic revenue growth in Q3 2026, driven by international performance and wholesale growth. Challenges in DTC, especially in the U.S. and Europe, were addressed with strategic initiatives. The company appointed John Vandemore as new CFO and expects mid-single-digit revenue growth in Q4. Operational highlights include international expansion and AI shopping assistant launch.

$LEVIHighAI 8/10

Earnings call transcript: Levi Strauss tops EPS in Q3 2026, shares fall on revenue miss

Levi Strauss reported Q3 2026 adjusted EPS of $0.48, beating estimates, but revenue of $1.61B missed forecasts. Shares fell 4.97% to $19.51, then dropped further in after-hours trading. The company maintained full-year guidance but slightly reduced reported revenue growth expectations due to FX pressure. Asia showed strong growth, while U.S. direct-to-consumer sales weakened. Management highlighted strategic shifts and long-term growth prospects.

$LEVIMedAI 8/10

Levi’s Raised Its Forecast, But US And Europe Looked Soft

Levi's raised its organic revenue growth and adjusted earnings guidance to $1.54-$1.56, citing strength in Asia and non-denim categories. However, US and Europe demand was weak, and the company received a $79M tariff refund, part of which will be used for promotions. Investors will focus on direct-to-consumer trends and margin sustainability.

$LEVIHighAI 8/10

Levi Strauss (LEVI) Reports Q3 EPS Beat, Updates FY26 Guidance

Levi Strauss (LEVI) reported Q3 non-GAAP EPS of $0.48, beating estimates by $0.12, with revenue up 4.5% YoY to $1.61B, slightly missing forecasts. The company raised FY26 guidance, projecting 7.0% revenue growth and adjusted EPS of $1.54-$1.56. LEVI offers a 2.88% dividend yield with a 45% payout ratio and a 7.1% 3-year dividend growth rate. The stock trades at $19.51, 7.4% below its GF Value of $21.06, reflecting reasonable valuation.